Skip to content

Medical-device intelligence

DKZ: Enzyme Immunoassay, Amphetamine

FDA product code DKZ: Enzyme Immunoassay, Amphetamine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DKZ
FDA device name
Enzyme Immunoassay, Amphetamine
Device class
2
Regulation number
862.3100
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

225 clearance records and 24 recall records in the covered releases, across 93 source company names and 1 product codes. Dated history runs from Aug 3, 1976 to Oct 30, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DKZ · Enzyme Immunoassay, Amphetamine22524

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

249 matching records
Device / recordCompany in FDA recordSourceSource date
VISUALINE II METHAMPHETIMINEK972032 · DKZSun Biomedical Laboratories, Inc.510(k)Aug 12, 1997FDA decision date
QUIKSTRIP ONE STEP METHAMPHETAMINEK970395 · DKZDrial Consultants, Inc.510(k)Jun 26, 1997FDA decision date
QUIKSTRIP ONE STEP AMPHETAMINE TESTK971218 · DKZDrial Consultants, Inc.510(k)May 30, 1997FDA decision date
QUIKPAC II ONE STEP AMPHETAMINE TESTK971109 · DKZDrial Consultants, Inc.510(k)May 14, 1997FDA decision date
QUICKPAC II ONE STEP METHAMPHETAMINE TESTK970724 · DKZDrial Consultants, Inc.510(k)May 13, 1997FDA decision date
ONE STEP URINE DRUG OF ABUSE METHAMPHETAMINE TESTK970265 · DKZDrial Consultants, Inc.510(k)Apr 8, 1997FDA decision date
ONTRAK TESTCUP AMPHETAMINESK962411 · DKZRoche Diagnostic Systems, Inc.510(k)Oct 7, 1996FDA decision date
TRIAGE PANEL FOR DRUGS OF ABUSE MODEL 9500/93000K955934 · DKZBiosite Incorporated510(k)Feb 16, 1996FDA decision date
TRIAGE PANEL FOR DRUGS OF ABUSE/TRICYCLIC ANTIDEPRESSANTSK955935 · DKZBiosite Incorporated510(k)Feb 15, 1996FDA decision date
AXSYM AMPHETAMINE/METHAMPHETAMINE IIK953115 · DKZAbbott Laboratories510(k)Oct 6, 1995FDA decision date
AMPHETAMINES MICRO-PLATE EIAK935573 · DKZSolarcare Technologies Corp,Inc.510(k)Jul 14, 1995FDA decision date
CEDIA DAU AMPHETAMINES ASSAYK951154 · DKZMicrogenics Corp.510(k)May 8, 1995FDA decision date
FINGERPRINT-DOAK942836 · DKZFingerprint Bioteck, Inc.510(k)May 1, 1995FDA decision date
ABUSIGN(TM) AMP, DOA-AMP, ACCUSIGN(TM) AMP-DOA-AMP, BIOSIGN(TM) AMP, DOA-AMPK945610 · DKZPrinceton BioMeditech Corp.510(k)Apr 13, 1995FDA decision date
URINE AMPHETAMINES SCREEN FLEX(TM) REAGENT CARTRIDGEK950135 · DKZE.I. Dupont DE Nemours & Co., Inc.510(k)Mar 30, 1995FDA decision date
EMIT(R) IIC AMPHETAMINE ASSAYK935352 · DKZSyva Co.510(k)Feb 22, 1995FDA decision date
ABUSIGN DOA4K943439 · DKZPrinceton BioMeditech Corp.510(k)Feb 22, 1995FDA decision date
CX AMPHETAMINES REAGENT FOR SYNCHRON CX SYSTEMSK944604 · DKZBeckman-Diagnostic Systems Group510(k)Dec 7, 1994FDA decision date
CEDIA DAU AMPHETAMINES ASSAYK943993 · DKZMicrogenics Corp.510(k)Oct 21, 1994FDA decision date
MICROLINE SCREEN FOR AMPHETAMINEK935052 · DKZDrug Screening Systems, Inc.510(k)Sep 16, 1994FDA decision date
CEDIA DAU AMPHETAMINES ASSAYK941372 · DKZMicrogenics Corp.510(k)Jul 20, 1994FDA decision date
ROCHE ABUSCREEN SAMPLE OXIDIZING REAGENTK935042 · DKZRoche Diagnostic Systems, Inc.510(k)Jan 25, 1994FDA decision date
AMPHETAMINES EIA ASSAY MODIFICATIONK934891 · DKZDiagnostic Reagents, Inc.510(k)Jan 13, 1994FDA decision date
MICRO EIA FOR AMPHETAMINE METABOLITESK932304 · DKZMicrodiagnostics, Inc.510(k)Dec 7, 1993FDA decision date
AMPHETAMINE TEST SYSTEMK934693 · DKZU.S. Drug Testing, Inc.510(k)Nov 22, 1993FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗